In this week’s interview we talk with one of the newer orthopedics players on the block – Enovis, the entity formerly known as Colfax. CEO Matthew L. Trerotola walks us through the decision to move from a diversified industrial player into an orthopedics company and just how the company thinks it can compete against larger, established players in the market. Enovis is weighted heavily in extremities, putting it on a track for fast growth, but sees promising signs it can compete in large joint as well.
You’ll also hear our latest Fastball Patch from Cellular Vehicles. This episode was sponsored by DeviceTalks Boston.
Thank you for listening to the DeviceTalks Weekly podcast.
Subscribe on any major podcast player.